• About us
• Contact

Advertisement

Organisation › Details

Artelis S.A.

Artelis, S.A., founded in 2005, collaborates with world-leading pharmaceutical groups to implement systems that meet the biotech industry's scale-up needs by developing high-cell-density technologies and related process techniques. The company's iCELLis(TM) bioreactor -- a high-cell-density, disposable cell culture platform -- enables process intensification by reducing bioreactor volumes while simplifying operations. With its partner ATMI, Artelis applies the benefits of single-use technologies to the production of antibodies, recombinant proteins, viruses, and cells with the iCELLis system. *

 

	Start	2005-01-01 established
	Group	Danaher (Group)
	Today	Danaher (Group)
	Industry	bioreactor, disposable
	Person	Castillo, José (Qunatoom Biosciences 202106– CEO + Univercells 2013– CTO + Co-Founder before Artelis 201011 President)
	Region	Brussels
	Country	Belgium
	Street	310 Rue de Ransbeek
	City	1120 Brussels
	Tel	+32-2-264-1880
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2011-01-16)
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
• [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
• [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [7] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
• [8] Ubiquigent Ltd.. (11/7/22). "Press Release: Ubiquigent Appoints Dr Hozefa Amijee as Head of Business Development". Dundee....
• [9] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [10] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.